Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 6829
116th Congress(2019-2020)
EMPIL–DOC Act
Introduced
Introduced
Introduced in House on May 12, 2020
Overview
Text
Introduced in House 
May 12, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 12, 2020)
May 12, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 6829 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 6829


To authorize funding for a bilateral cooperative program with Israel for the development of health technologies with a focus on combating COVID-19.

IN THE HOUSE OF REPRESENTATIVES

May 12, 2020

Mr. Pappas (for himself, Mr. Gooden, Mr. Suozzi, and Mr. Kustoff of Tennessee) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To authorize funding for a bilateral cooperative program with Israel for the development of health technologies with a focus on combating COVID-19.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Expanding Medical Partnerships with Israel to Lessen Dependence on China Act” or the “EMPIL–DOC Act”.

SEC. 2. Bilateral cooperative agreement.

(a) Authorization of appropriations.—There is authorized to be appropriated to the Secretary of Health and Human Services $4,000,000 for each of fiscal years 2021 through 2023 for a bilateral cooperative program with the Government of Israel for awarding grants for the development of health technologies, including such technologies described in subsection (b), subject to subsection (c), with an emphasis on collaboratively advancing the use of technology, personalized medicine, and data in relation to COVID-19.

(b) Types of health technologies.—The health technologies described in this subsection shall include technologies such as artificial intelligence, drugs and vaccinations, respiratory assist devices, diagnostic tests, and telemedicine.

(c) Restrictions on funding.—The funding under subsection (a) is subject to a matching contribution from the Government of Israel.

(d) Option for establishing new program.—The amounts appropriated under subsection (a) may be—

(1) for a bilateral program with the Government of Israel that is in existence on the day before the date of enactment of this Act for the purposes described in such subsection; or

(2) for a bilateral program with the Government of Israel that is established after the date of enactment of this Act by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a successor agreement), for the purposes described in subsection (a).